InnovAge Holding Corp. (NASDAQ:INNV – Free Report) – Equities researchers at William Blair lowered their FY2025 earnings per share (EPS) estimates for shares of InnovAge in a report issued on Tuesday, May 6th. William Blair analyst J. Haase now expects that the company will post earnings per share of ($0.23) for the year, down from their previous forecast of ($0.15). The consensus estimate for InnovAge’s current full-year earnings is ($0.12) per share.
InnovAge (NASDAQ:INNV – Get Free Report) last announced its earnings results on Tuesday, May 6th. The company reported ($0.08) EPS for the quarter, missing the consensus estimate of ($0.02) by ($0.06). The company had revenue of $218.14 million for the quarter, compared to the consensus estimate of $214.09 million. InnovAge had a negative return on equity of 9.45% and a negative net margin of 3.19%.
InnovAge Price Performance
Institutional Inflows and Outflows
Large investors have recently added to or reduced their stakes in the company. Barclays PLC increased its position in InnovAge by 13.6% during the fourth quarter. Barclays PLC now owns 29,099 shares of the company’s stock worth $115,000 after acquiring an additional 3,485 shares during the period. Charles Schwab Investment Management Inc. increased its holdings in shares of InnovAge by 2.8% during the first quarter. Charles Schwab Investment Management Inc. now owns 164,322 shares of the company’s stock worth $490,000 after purchasing an additional 4,535 shares during the period. Bank of America Corp DE raised its position in shares of InnovAge by 42.4% in the fourth quarter. Bank of America Corp DE now owns 19,945 shares of the company’s stock valued at $78,000 after buying an additional 5,936 shares in the last quarter. SG Americas Securities LLC bought a new stake in shares of InnovAge in the fourth quarter valued at approximately $43,000. Finally, Northern Trust Corp grew its position in InnovAge by 4.7% during the fourth quarter. Northern Trust Corp now owns 330,099 shares of the company’s stock worth $1,297,000 after buying an additional 14,900 shares in the last quarter. Institutional investors own 12.26% of the company’s stock.
About InnovAge
InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management.
Featured Articles
- Five stocks we like better than InnovAge
- What is a buyback in stocks? A comprehensive guide for investors
- Google Is Betting Big on Nuclear Reactors—Should You?
- Dividend Payout Ratio Calculator
- Taiwan Semiconductor Has a New Reason to Rally on Chip Curbs
- What to Know About Investing in Penny Stocks
- Why Nearly 20 Analysts Raised Meta Price Targets Post-Earnings
Receive News & Ratings for InnovAge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InnovAge and related companies with MarketBeat.com's FREE daily email newsletter.